Jackson Center, Pennsylvania / Accesswire / October 27, 2022 / William A. Hartman, Chairman, President and CEO of Halberd Corporation (OTC PINK:HALB) and Mitchell S. Felder, Ph.D., Chief Technology Officer of Halberd Corporation (OTC PINK:HALB), said in an interview with The Street Reports that their study has shown significant We talked about milestones and how it can be revolutionary. The health care sector and its possible impact on the treatment of many diseases.
Listen here: https://thestreetreports.com/the-street-reports-podcast-features-halberd-corporations-otc-halb-ceo-william-hartman-and-chief-technology-officer-dr-mitchell- s-felder – listen now/
Send this and subscribe to get the latest news on Halberd’s exciting developments.
For more information, please contact:
William A. Hartman
Halberd Corporation (OTC-PINK:HALB) is an OTC Markets publicly traded company and is fully compliant with the OTC Markets reporting requirements. Since the April 2020 reorganization, Halvard has obtained worldwide exclusive rights to three issued patents and has filed 22 related provisional, PCT or utility patent applications, increasing value for shareholders. , has attracted the interests of potential development partners.
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). We caution readers that the statements and assumptions made in this news release are forward-looking statements and are not guarantees of future performance. Forward-looking statements are based on management’s estimates and opinions as of the date the statements are made. These statements may address matters involving material risks, uncertainties and related estimates made by management. Actual results could differ materially from current projections or implied results. Halberd Corporation does not undertake any obligation to revise these statements after the date of this news release.
sauce: halberd corporation